Photo: Adam Watt/NYU Langone Medical CenterA new device may hold the promise of eliminating an anguishing part of many breast-cancer surgeries: a follow-up operation to remove lingering cancer cells. Dr. Schnabel estimates they are as much as 20% to 30% nationally. A 26-year veteran of breast surgery, she hates telling patients she failed to achieve a clean margin. Dr. Schnabel, director of breast surgery at NYU Langone’s Perlmutter Cancer Center, says the MarginProbe has the potential to make breast-cancer surgery more effective. She found herself wondering, “Should I have had them take the whole breast?” Dr. Schnabel was reassuring; she had used MarginProbe, and the margins turned out clean.

Source: Wall Street Journal February 06, 2017 14:37 UTC